The sequestration of α-synuclein in Lewy bodies has been hypothesized to have pathological effects as a consequence of α-synuclein depletion [2]; perhaps the trapping of NMNAT2 found in insoluble fractions in the brain of AD patients restrains NMNAT2 from acting as a chaperone. This evidence concerns the gene NMNAT2 and Alzheimer disease.